CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing prevalence of chronic diseases and disorders
4.1.2. Increasing in healthcare expenditure
4.1.3. Increase in premature births
4.1.4. Growing demand for homecare
4.2. Market Restraints & Challenges
4.2.1. Patient safety risk
4.2.2. Complications associated with enteral feeding
4.3. Market Opportunities
4.3.1. Emerging economies
4.3.2. The emergence of point-of-care Enteral Feeding Formulas devices
CHAPTER 5. GLOBAL ENTERAL FEEDING FORMULAS MARKET – BY STAGE
5.1. Paediatrics
5.2. Adults
CHAPTER 6. GLOBAL ENTERAL FEEDING FORMULAS MARKET – BY
PRODUCT
6.1. Standard Formulas
6.2.1 Polymeric Formulas
6.2.2 Monomeric Formulas
6.3. Disease-Specific Formulas
6.3.1 Diabetic Formulas
6.3.2 Renal Formulas
6.3.3 Hepatic Formulas
6.3.4 Pulmonary Formulas
6.3.5 Other Formulas
CHAPTER 7. GLOBAL ENTERAL FEEDING FORMULAS MARKET – BY
APPLICATION
7.1. Oncology
7.2. Gastroenterology
7.3. Neurology
7.4. Diabetes
7.5. Critical Care
7.6. Other Applications
CHAPTER 8. GLOBAL ENTERAL FEEDING FORMULAS MARKET – BY END
USER
8.1. Hospitals
8.2. Long-Term Care Facilities
8.2.1. Home Care Agencies and Hospices
8.2.2. Nursing Homes
8.2.3. Assisted Living Facilities
CHAPTER 9. GLOBAL ENTERAL FEEDING FORMULAS MARKET - BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
10.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL ENTERAL FEEDING FORMULAS MARKET - COMPANY
PROFILES
10.1. Abbott Laboratories
10.2. Nestle S.A
10.3. Danone S.A
10.4. Fresenius Kabi AG
10.5. Mead Johnson Nutritional Company
10.6. Hormel Foods Corporation
10.7. Victus, Inc.
10.8. Global Health Products Inc.
10.9. Meiji Holding Co, Ltd.
10.10. B. Braun Melsungen AG
10.11. Halyard Health Inc.
10.12. Boston Scientific Corporation
10.13. Dynarex Corporation
CHAPTER 11. GLOBAL ENTERAL FEEDING FORMULAS MARKET
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
